Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Neuropsychopharmacology (69)
Molecular Psychiatry (8)
Journal of Human Genetics (1)
Oncogene (1)
Pediatric Research (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (72)
Reviews (5)
News (2)
Comments & Opinion (1)
Editorial (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Biological techniques
Chemical biology
Diseases
Health care
Neuroscience
Physiology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–50 of 81 results

Advanced filters: Author: D Pickar Clear advanced filters

Beneficial Effects of Nalmefene Augmentation in Neuroleptic-Stabilized Schizophrenic Patients

Mark Hyman Rapaport
Owen Wolkowitz
David Pickar
Research01 Sept 1993
Neuropsychopharmacology

Volume: 9, P: 111-115
The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy

Alan Breier
Robert W. Buchanan
David S. Goldstein
Research01 Feb 1994
Neuropsychopharmacology

Volume: 10, P: 1-7
Dopamine Turnover in Schizophrenia Before and after Haloperidol Withdrawal

M Beuger
DP van Kammen
J Yao
Research01 Jul 1996
Neuropsychopharmacology

Volume: 15, P: 75-86
Effects of Clozapine on Plasma Catecholamines and Relation to Treatment Response in Schizophrenia: A Within-Subject Comparison with Haloperidol

Alan S Brown
George Gewirtz
Jack M Gorman
Research01 Nov 1997
Neuropsychopharmacology

Volume: 17, P: 317-325
Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-II

James W. Maas
Salvador A. Contreras
Susan E. Weintraub
Research01 Feb 1993
Neuropsychopharmacology

Volume: 8, P: 111-116
Plasma Catecholamine Metabolites as Markers for Psychosis and Antipsychotic Response in Schizophrenia

Mary E Kelley
Jeffrey K Yao
Daniel P van Kammen
Research01 Jun 1999
Neuropsychopharmacology

Volume: 20, P: 603-611
Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-I

James W. Maas
Salvador A. Contreras
Susan Weintrub
Research01 Feb 1993
Neuropsychopharmacology

Volume: 8, P: 97-109
Mechanism of Peripheral Noradrenergic Stimulation by Clozapine

Igor Elman
David S Goldstein
Alan Breier
Research01 Jan 1999
Neuropsychopharmacology

Volume: 20, P: 29-34
Endogenous Opioid Activity Is Associated with Obsessive-Compulsive Symptomology in Individuals with a Family History of Alcoholism

Deborah L Mangold
Mark Peyrot
Gary S Wand
Research01 Jun 2000
Neuropsychopharmacology

Volume: 22, P: 595-607
Naloxone-Induced Pituitary-Adrenal Activation Does Not Differ in Patients with Depression, Obsessive Compulsive Disorder, and Healthy Controls

David Michelson
Margaret Altemus
Philip Gold
Research01 Aug 1996
Neuropsychopharmacology

Volume: 15, P: 207-212
Positron-Emission Tomography and Personality Disorders

Peter F. Goyer
Paul J. Andreason
Robert M. Cohen
Research01 Feb 1994
Neuropsychopharmacology

Volume: 10, P: 21-28
Temporal Lobe Metabolic Differences in Medication-Free Outpatients with Schizophrenia via the PET-600

Thomas E Nordahl
Natalia Kusubov
Thomas F Budinger
Research01 Dec 1996
Neuropsychopharmacology

Volume: 15, P: 541-554
Attempted Suicide Characteristics and Cerebrospinal Fluid Amine Metabolites in Depressed Inpatients

J John Mann
Kevin M Malone
Michael Stanley
Research01 Dec 1996
Neuropsychopharmacology

Volume: 15, P: 576-586
Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia

Barbara K. Lipska
George E. Jaskiw
Daniel R. Weinberger
Research01 Aug 1993
Neuropsychopharmacology

Volume: 9, P: 67-75
The D₂ receptor: love it and leave it

D Pickar
News30 Apr 1998
Molecular Psychiatry

Volume: 3, P: 101-102
Delusional Disorder: Molecular Genetic Evidence for Dopamine Psychosis

Kiyoshi Morimoto
Ryosuke Miyatake
Hiroshi Suwaki
Research28 Nov 2001
Neuropsychopharmacology

Volume: 26, P: 794-801
Effects of Risperidone on the Peripheral Noradrenegic System in Patients with Schizophrenia: A Comparison with Clozapine and Placebo

Igor Elman
David S Goldstein
Alan Breier
Research28 Feb 2002
Neuropsychopharmacology

Volume: 27, P: 293-300
Etiologic Heterogeneity of the Psychoses: Is There a Dopamine Psychosis?

David L Garver
Joel L Steinberg
Steven J Kingsbury
Research01 Mar 1997
Neuropsychopharmacology

Volume: 16, P: 191-201
The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic Inpatients

Anne L Hoff
William O Faustman
John G Csernansky
Research01 Oct 1996
Neuropsychopharmacology

Volume: 15, P: 361-369
Lack of linkage between the corticotropin-releasing hormone (CRH) gene and bipolar affective disorder

C A Stratakis
N J Sarlis
S D Detera-Wadleigh
Research01 Oct 1997
Molecular Psychiatry

Volume: 2, P: 483-485
Clozapine Reverses the Spatial Working Memory Deficits Induced by FG7142 in Monkeys

Beth L Murphy
Robert H Roth
Amy FT Arnsten
Research01 Jun 1997
Neuropsychopharmacology

Volume: 16, P: 433-437
Differential Distribution of Corticotropin-Releasing Hormone Immunoreactive Axons in Monoaminergic Nuclei of the Human Brainstem

Mark C Austin
James L Rhodes
David A Lewis
Research01 Nov 1997
Neuropsychopharmacology

Volume: 17, P: 326-341
Abnormalities in the Distributed Network of Sustained Attention Predict Neuroleptic Treatment Response in Schizophrenia

Robert M Cohen
Thomas E Nordahl
David Pickar
Research01 Jul 1998
Neuropsychopharmacology

Volume: 19, P: 36-47
Effect of Mental Stress on Plasma Homovanillic Acid in Healthy Human Subjects

Tomiki Sumiyoshi
Takashi Yotsutsuji
Osamu Saitoh
Research01 Jul 1998
Neuropsychopharmacology

Volume: 19, P: 70-73
Neuropsychologic Deficits in Schizophrenia

Herbert Y Meltzer
Paul A Thompson
Rakesh Ranjan
Research01 Mar 1996
Neuropsychopharmacology

Volume: 14, P: 27-33
The dopamine D₃ receptor (DRD3) Ser₉Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response

A K Malhotra
D Goldman
D Pickar
Research24 Feb 1998
Molecular Psychiatry

Volume: 3, P: 72-75
Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT_2A receptor gene and response to clozapine

M J Arranz
J Munro
R W Kerwin
Research24 Feb 1998
Molecular Psychiatry

Volume: 3, P: 61-66
Genomic organization and promoter analysis of human KCNN3 gene

G. Sun
H. Tomita
J. J. Gargus
Research01 Aug 2001
Journal of Human Genetics

Volume: 46, P: 463-470
Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart

Systemic modulation of branched-chain keto acid (BCKA) metabolism alters cardiac health. Here, the authors define the major fates of BCKA in the heart and demonstrate that acute exposure to BCKA levels found in obesity activates cardiac protein synthesis and markedly alters the heart phosphoproteome.

Jacquelyn M. Walejko
Bridgette A. Christopher
Robert W. McGarrah
ResearchOpen Access15 Mar 2021
Nature Communications

Volume: 12, P: 1-14
The Brain Metabolic Patterns of Clozapine- and Fluphenazine-Treated Female Patients with Schizophrenia: Evidence of a Sex Effect

Robert M Cohen
Thomas E Nordahl
David Pickar
Research01 Nov 1999
Neuropsychopharmacology

Volume: 21, P: 632-640
On the Value of Measuring Dopamine, Norepinephrine and Their Metabolites in Schizophrenia

René S. Kahn
Michael Davidson
Editorial01 Feb 1993
Neuropsychopharmacology

Volume: 8, P: 93-95
The Effect of Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of Schizophrenic Patients

Floortje E Scheepers
Christine C Gispen-de Wied
René S Kahn
Research09 Mar 2001
Neuropsychopharmacology

Volume: 25, P: 468-475
Cerebrospinal Fluid Levels of Monoamine Metabolites

Elias Eriksson
Christer Alling
Ulf Berggren
Research01 Nov 1994
Neuropsychopharmacology

Volume: 11, P: 201-213
NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers

Anil K Malhotra
Debra A Pinals
Alan Breier
Research01 May 1996
Neuropsychopharmacology

Volume: 14, P: 301-307
Cerebrospinal Fluid Concentrations of Corticotropin-Releasing Hormone (CRH) and Diazepam-Binding Inhibitor (DBI) during Alcohol Withdrawal and Abstinence

Bryon Adinoff
Ray Anton
Garth Bissette
Research01 Sept 1996
Neuropsychopharmacology

Volume: 15, P: 288-295
Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis

FX Vollenweider
KL Leenders
J Angst
Research01 May 1997
Neuropsychopharmacology

Volume: 16, P: 357-372
Plasma Homovanillic Acid and Performance on Motor and Cognitive Tasks in Community-Dwelling Elderly: MacArthur Studies of Successful Aging

Farooq Amin
Teresa E. Seeman
Dan Blazer
Research01 Feb 1994
Neuropsychopharmacology

Volume: 10, P: 29-35
Efficacy and Side-Effects of Clozapine: Testing for Association with Allelic Variation in the Dopamine D₄ Receptor Gene

Marcella Rietschel
Dieter Naber
Markus M Nöthen
Research01 Nov 1996
Neuropsychopharmacology

Volume: 15, P: 491-496
Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects

Y L Hurd
M M Herman
J E Kleinman
Research01 Oct 1997
Molecular Psychiatry

Volume: 2, P: 495-500
Probing GABA Receptor Function in Schizophrenia with Iomazenil

Kyungheup Ahn
Roberto Gil
Deepak Cyril D'Souza
Research10 Nov 2010
Neuropsychopharmacology

Volume: 36, P: 677-683
Differential Inhibition of Neuronal and Extraneuronal Monoamine Oxidase

Graeme Eisenhofer
Jacques W M Lenders
Irwin J Kopin
Research01 Sept 1996
Neuropsychopharmacology

Volume: 15, P: 296-301
Corticotropin Releasing Hormone Stimulation Test and Nocturnal Cortisol Levels in Normal Children

Ronald E Dahl
Selma F Siegel
Neal D Ryan
Research01 Jul 1992
Pediatric Research

Volume: 32, P: 64-68
Central Muscarinic Acetylcholine Receptor Availability in Patients Treated with Clozapine

Thomas J Raedler
Michael B Knable
Daniel R Weinberger
Research28 Apr 2003
Neuropsychopharmacology

Volume: 28, P: 1531-1537
A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter

G Spurlock
A Heils
M J Owen
Research24 Feb 1998
Molecular Psychiatry

Volume: 3, P: 42-49
Psychopharmacology and the Etiology of Psychopathologic States: Are We Looking in the Right Way?

Martin M. Katz
James W. Maas
Research01 Apr 1994
Neuropsychopharmacology

Volume: 10, P: 139-144
Differential Effects of Mental Stress on Plasma Homovanillic Acid in Schizophrenia and Normal Controls

Tomiki Sumiyoshi
Osamu Saitoh
Masayoshi Kurachi
Research01 Apr 1999
Neuropsychopharmacology

Volume: 20, P: 365-369
Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy

Joseph I Friedman
Jean-Pierre Lindenmayer
Kenneth L Davis
Research23 Feb 2011
Neuropsychopharmacology

Volume: 36, P: 1289-1295
Evaluation of Dopamine D-2 Receptor Occupancy by Clozapine, Risperidone, and Haloperidol In Vivo in the Rodent and Nonhuman Primate Brain Using ¹⁸F-Fallypride

Jogeshwar Mukherjee
Bradley T Christian
Joseph Mantil
Research06 Mar 2001
Neuropsychopharmacology

Volume: 25, P: 476-488
M100907, A Selective 5-HT_2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate–Receptor Mediated Neurotransmission in the Rat Medial Prefrontal Cortical Neurons In Vitro

Viktor L Arvanov
Rex Y Wang
Research01 Mar 1998
Neuropsychopharmacology

Volume: 18, P: 197-209
Is the Time Course of Clozapine Response Correlated to the Time Course of Clozapine Plasma Levels? A One-Year Prospective Study in Drug-Resistant Patients with Schizophrenia

Michele Fabrazzo
Silvestro La Pia
Mario Maj
Research27 Feb 2002
Neuropsychopharmacology

Volume: 27, P: 1050-1055

Previous page
page 1
page 2
Next page

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

© 2025 Springer Nature Limited